HEXIM1 Regulates 17β-Estradiol/Estrogen Receptor-α–Mediated Expression of Cyclin D1 in Mammary Cells via Modulation of P-TEFb
Open Access
- 28 August 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (17) , 7015-7024
Abstract
Estrogen receptor α (ERα) plays a key role in mammary gland development and is implicated in breast cancer through the transcriptional regulation of genes linked to proliferation and apoptosis. We previously reported that hexamethylene bisacetamide inducible protein 1 (HEXIM1) inhibits the activity of ligand-bound ERα and bridges a functional interaction between ERα and positive transcription elongation factor b (P-TEFb). To examine the consequences of a functional HEXIM1-ERα-P-TEFb interaction in vivo, we generated MMTV/HEXIM1 mice that exhibit mammary epithelial-specific and doxycycline-inducible expression of HEXIM1. Increased HEXIM1 expression in the mammary gland decreased estrogen-driven ductal morphogenesis and inhibited the expression of cyclin D1 and serine 2 phosphorylated RNA polymerase II (S2P RNAP II). In addition, increased HEXIM1 expression in MCF-7 cells led to a decrease in estrogen-induced cyclin D1 expression, whereas down-regulation of HEXIM1 expression led to an enhancement of estrogen-induced cyclin D1 expression. Studies on the mechanism of HEXIM1 regulation on estrogen action indicated a decrease in estrogen-stimulated recruitment of ERα, P-TEFb, and S2P RNAP II to promoter and coding regions of ERα-responsive genes pS2 and CCND1 with increased HEXIM1 expression in MCF-7 cells. Notably, increased HEXIM1 expression decreased only estrogen-induced P-TEFb activity. Whereas there have been previous reports on HEXIM1 inhibition of P-TEFb activity, our studies add a new dimension by showing that E2/ER is an important regulator of the HEXIM1/P-TEFb functional unit in breast cells. Together, these studies provide novel insight into the role of HEXIM1 and ERα in mammary epithelial cell function. [Cancer Res 2008;68(17):7015–24]Keywords
All Related Versions
This publication has 47 references indexed in Scilit:
- The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1Oncogene, 2005
- c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosisOncogene, 2003
- Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors.2003
- Activation and function of cyclin T–Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophyNature Medicine, 2002
- Reciprocal Recruitment of DRIP/Mediator and p160 Coactivator Complexes in Vivo by Estrogen ReceptorJournal of Biological Chemistry, 2002
- A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biologyThe FASEB Journal, 2002
- Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domainGenes & Development, 2001
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- Estrogen receptor pathways to AP-1The Journal of Steroid Biochemistry and Molecular Biology, 2000
- Mammary Gland Development and Tumorigenesis in Estrogen Receptor Knockout MiceJournal of Mammary Gland Biology and Neoplasia, 1997